NCT04236986View on ClinicalTrials.gov

Imaging the Neuroimmune System in PTSD

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

Lipopolysaccharide

LPS will be administered intravenously (1.0ng/kg; IV)

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER

NCT04236986 - Imaging the Neuroimmune System in PTSD | Biotech Hunter | Biotech Hunter